 Good morning. This is your boy rich here and we have a rich TV live. I wanted to bring to your attention another big winner Adma biologics a DMA they just got FDA approval and The stock is running pre-market up 54% at $6.29 They've got a price target at Nasdaq comm at over $11. It's running pre-market. It closed at $4.07 yesterday It's up 53% pre-market at $6.25 right now And I think it could go even higher put on your watch list put on your radar This could be one of the biggest winners of the day They just got FDA approval and I want to make sure you know about it first Thank you for watching smash the like button comment down below share this video everywhere Put a DMA on full alert. I think this bad boy is gonna fly you can book it This is your boy rich from rich TV live. We bring you the winners and we bring them do we bring them to you first A DMA they just received FDA approval. Take a look at the news It is trending. It is circulating. It is blowing up and I think it could go even Higher. There's the news. It is circulating everywhere Adma biologics Inc Received FDA approval. It's big. It's the only company that received FDA approval today I'm gonna go back to do more research. I'm gonna do more due diligence market opens in 15 minutes But I have to drop this news before the market opens so you guys know first. All right, your boy. I'm out. Peace